Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real-world study Journal:Diabetes, Obesity and Metabolism | 5-Nov-2024 |
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real-world study Journal:Diabetes, Obesity and Metabolism | 5-Nov-2024 |